Provided by Tiger Trade Technology Pte. Ltd.

Estrella Immunopharma

0.7353
-0.0097-1.30%
Post-market: 0.73530.00000.00%19:15 EDT
Volume:8K
Turnover:6.10K
Market Cap:31.98M
PE:-2.90
High:0.7605
Open:0.7605
Low:0.7206
Close:0.7450
52wk High:3.15
52wk Low:0.6781
Shares:43.50M
Float Shares:14.57M
Volume Ratio:0.19
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2536
EPS(LYR):-0.3548
ROE:-268.50%
ROA:-251.86%
PB:-4.30
PE(LYR):-2.07

Loading ...

Estrella Immunopharma Gets NASDAQ Notice After ESLA Bid Price Stays Below $1 for 30 Days

Reuters
·
Aug 22

Estrella Immunopharma FY26 Q2 Net Loss Narrows 58.18% to $2.3 Million

Reuters
·
Aug 14

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/Ii Starlight-1 Trial in B-Cell Non-Hodgkin’s Lymphoma

THOMSON REUTERS
·
Aug 11

Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/Ii Starlight-1 Trial in B-Cell Non-Hodgkin’s Lymphoma

THOMSON REUTERS
·
Aug 03

Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial

TIPRANKS
·
Jul 24

Estrella Immunopharma Doses First Patient in Starlight-1 Trial Expansion for EB103 in Relapsed B-cell NHL

Reuters
·
Jul 24

Estrella Immunopharma Announces First Patient Dosed in Dose-expansion Phase of Starlight-1 Trial and Reports Durable Response Rate in Advanced B-cell Non-hodgkin’s Lymphoma

THOMSON REUTERS
·
Jul 24

Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment

TIPRANKS
·
Jul 01

Estrella Immunopharma Holds Annual Stockholders Meeting Via Virtual Webcast

Reuters
·
Jul 01

Estrella Immunopharma announces annual shareholder meeting

Reuters
·
May 28

Estrella Immunopharma Q1 EPS $(0.05) Beats $(0.18) Estimate

Benzinga Earnings
·
May 18

Estrella Immunopharma Q1 net loss widens to $2.3 million from year-ago quarter

Reuters
·
May 18

Estrella Immunopharma delays quarterly report filing on administrative delay

Reuters
·
May 18

Estrella Immunopharma to join D. Boral Capital Global Conference investor meetings

Reuters
·
May 05

Estrella Immunopharma CFO Jiandong Xu buys common shares worth $1,437.8

Reuters
·
Apr 30

Estrella Immunopharma FY 2025 net loss widened 48.86% to USD 13.1 million

Reuters
·
Mar 18